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EDITORIAL 
Lipids in Cancer Cell Biology and Therapy 
Cancer-related morbidity is one of the leading causes of deaths in the world. Due to the social and 
health impact of cancer, research on cellular and molecular pathways leading to oncogenesis and 
carcinogenesis is one of the most active areas of biomedical investigation. Moreover, the 
uncovering of pathways that foster cancer growth and cell death resistance may also result in the 
development of more efficient therapeutic options for the treatment of cancer. In this special 
issue of Anti Cancer Agents in Medicinal Chemistry, a group of expert leaders summarize emerging 
evidence on the exciting role of cholesterol and sphingolipids (SLs) in the regulation of cancer cell 
biology and therapy. In addition to playing a key structural role in biological membranes, recent 
data have uncovered a critical function for cholesterol and SLs in the modulation of essential 
pathways involved in cancer cell biology. Particularly, ceramide and cholesterol regulate cell death 
pathways and hence play a crucial role in determining the susceptibility of cancer cells to current 
therapy, thus providing a rationale for novel therapeutic combinations. 
In this regard, Ballereau et al., examine the role of ceramide functionalization at the C1-OH 
position as a promising approach for cancer therapy. Although ceramide is well recognized as a 
proapoptotic lipid moiety, ceramide metabolism in cancer cells is altered giving rise to other 
metabolites involved in tumor progression and drug resistance. The authors review data indicating 
the key role of enzymes that modify ceramide at the C1-OH position generating other biologically 
important SLs in cancer, such as sphingomyelin, ceramide-1-phosphate or glucosylceramide. Thus, 
modulating these enzymes may open novel opportunities for improving current chemotherapy. 
In the review by Mullen and Obeid, the authors provide an extensive overview of the role of 
ceramide and apoptosis. In particular, the authors explore enigmatic connections between 
sphingolipid metabolism and programmed cell death, particularly focussing on the role of de novo 
sphingolipid synthesis and sphingosine salvage in producing proapoptotic ceramide, involving 
mitochondrial membrane permeabilization. Due to the critical role of mitochondria in the 
regulation of cell death pathways this connection may be of relevance in regulating cancer cells 
susceptibility to apoptosis and chemotherapy. Along these lines, Delgado et al., summarize SLs 
metabolism and provide evidence for the role of sphingolipid analogs as metabolic modulators in 
cancer cell therapy.  
Of significance for solid tumors like renal carcinomal and liver cancer, the authors present data 
exploring the role of sorafenib with sphingosine kinase inhibitors to modulate cancer cell death 
susceptibility and the development of novel small 
molecule inhibitors of SLs metabolism to potentiate current therapy. In addition to the role of 
ceramide in apoptosis regulation, this lipid can also serve as a precursor for complex 
glycosphingolipids, including gangliosides. Sorice et al., review the role of ganglioside GD3 in cell 
death regulation. They provide compelling evidence linking the trafficking of GD3 to mitochondrial 
membranes to regulate the susceptibility of cells to Fas-mediated apoptosis. Intriguingly, GD3, by 
interacting with mitochondrial raft-like microdomains, may trigger specific events involved in the 
apoptogenic program, introducing an additional task for identifying new molecular targets of anti-
cancer agents. 
As a key component of biological bilayers, cholesterol has emerged as a modulator of cell death 
pathways with a potential role in cancer cell therapy. In this respect, Lucken-Ardjomande (5) 
presents current evidence about the role of cholesterol in modulating mitochondria 
membrane permeabilization. In this novel function, cholesterol regulates mitochondrial 
membrane physical properties determining the ability of proapoptotic Bcl-2 family members to 
permeabilize mitochondria and engage the apoptosome. 
As one of the leading causes of cancer-related deaths, Morales et al., review the role of 
cholesterol and ceramide in hepatocellular carcinoma. The authors focus on the emerging role of 
mitochondrial cholesterol in determining the susceptibility of hepatocellular carcinoma 
to chemotherapy, opening the possibility for designing novel targets for treatment and the 
rationale for proposing combined therapies with current agents and inhibitors/modulators of 
cholesterol and ceramide metabolism. 
Finally, related to the role of cholesterol in cancer, Garcia-Ruiz et al., explore the effects of statins 
and protein prenylation in cancer cell biology and therapy. Targeting the heart of the mevalonate 
pathway, statins not only reduce the synthesis of cholesterol but blunt the synthesis of 
isoprenoids and hence alter protein-prenylation, a critical event in the posttranslational 
modulation of proteins involved in the regulation of cell cycle progression, proliferation and 
signaling pathways, including the Hedgehog pathway. Current trials indicate a potential beneficial 
role of statins in different solid tumors, including colorectal, pancreatic and liver cancer. However, 
the potential of combined therapy with statins and currently used chemotherapeutic agents in 
these prevalent cancer types needs to be further explored. 
We hope this collection of timely reviews may spark the interest in this field of oncology and 
promote more basic research to understand the role of cholesterol/ceramide in cancer cell biology 
to exploit their potential as novel anticancer strategies. 
 
